BioMarin Pharmaceutical
BMRN
#1885
Rank
S$13.81 B
Marketcap
S$71.92
Share price
-0.79%
Change (1 day)
-17.03%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): S$0.89 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are S$3.09 Billion. In 2024 the company made an earning of S$0.68 Billion, an increase over its 2023 earnings that were of S$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.89 B29.86%
2024 S$0.68 B187.31%
2023 S$0.23 B26.07%
2022 S$0.19 B-298.51%
2021 -S$95.86 Million78.04%
2020 -S$53.84 Million-55.36%
2019 -S$0.13 Billion-33.56%
2018 -S$0.19 Billion297.78%
2017 -S$45.64 Million-95.68%
2016 -S$1.06 Billion437.12%
2015 -S$0.2 Billion23.91%
2014 -S$0.16 Billion-29.25%
2013 -S$0.23 Billion49.23%
2012 -S$0.16 Billion171.11%
2011 -S$55.5 Million103.01%
2010 -S$27.34 Million-3903.54%
2009 S$0.71 M-98.31%
2008 S$42.51 M-189.7%
2007 -S$47.41 Million51.02%
2006 -S$31.39 Million-61.58%
2005 -S$81.69 Million-56.59%
2004 -S$0.19 Billion95.13%
2003 -S$96.43 Million12.09%
2002 -S$86.03 Million73.19%
2001 -S$49.68 Million18.32%
2000 -S$41.99 Million19.65%
1999 -S$35.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
S$11.57 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-S$0.66 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.14 Billion-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$34.91 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$6.33 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$0.36 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA